HPQ · Hp Inc · Insider Trading

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 3/10/2026.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 3/10/2026.

Each RSU represents a contingent right to receive one share of HP common stock.

On 8/5/2024, the reporting person was granted 458,015 RSUs, 1/3 of which vest annually over 3 years on 8/5/2025, 8/5/2026 and 8/5/2027, respectively. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 14,074 dividend equivalent units.

Shares withheld by HP to satisfy tax withholding upon vesting of Restricted Stock Units ("RSUs").

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 3/10/2026.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 3/10/2026.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 3/10/2026.

Shares withheld by HP to satisfy tax withholding upon vesting.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

As previously reported, on 7/14/2025, the reporting person was granted 64,438 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 7/14/2025. Dividend equivalent units ("DEUs") accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,158 vested DEUs.

The 45,272 shares reported in column 9 includes 2,313 unvested DEUs.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 3/10/2026.

Includes 925 shares acquired under HP's 2021 employee stock purchase plan on 3/13/2026.

On 04/16/2026, the reporting person was granted 12,176 restricted stock units, all of which vested on the grant date.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date.

The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date.

The reporting person elected to defer the receipt of common stock until 04/01/2033.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date.

The reporting person elected to defer the receipt of common stock until 04/01/2029.

On 04/16/2026, the reporting person was granted 12,176 restricted stock units, all of which vested on the grant date.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date.

The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

On 04/16/2026, the reporting person was granted 12,176 restricted stock units, all of which vested on the grant date.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date.

The reporting person elected to defer the receipt of common stock until the termination of his service as a member of HP's Board of Directors.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 6,088 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

The reporting person elected to defer the receipt of common stock until 04/01/2033.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date.

The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 6,088 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date.

The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date.

The reporting person elected to defer the receipt of common stock until 04/01/2033.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 04/16/2026, the reporting person was granted 6,088 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer.

The reporting person elected to defer the receipt of common stock until the termination of his service as a member of HP's Board of Directors.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

As previously reported, on April 23, 2019, the Reporting Person was granted 7,965 RSUs, all of which vested on the grant date; however, the Reporting Person elected to defer the receipt of common stock until April 1, 2026. Dividend equivalent rights accrued with respect to these RSUs when and as dividends were paid on HP common stock. The number of derivative securities in column 5 includes 1,916 vested dividend equivalent rights.

On May 5, 2016, the Reporting Person was granted an option to purchase 48,544 shares, vesting in full on the one-year anniversary of the grant date.

On May 5, 2016, the Reporting Person was granted an option to purchase 72,816 shares, vesting in full on the one-year anniversary of the grant date.

Represents shares sold to cover the exercise price and broker fees and commissions in connection with the exercise of stock options.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.315 to $18.545, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The number of shares shown includes 652.70 shares acquired through the Reporting Person's participation in a dividend reinvestment plan.

The number of shares shown includes 652.70 shares acquired through the Reporting Person's participation in a dividend reinvestment plan.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 3/2/2026, the reporting person was granted 157,729 RSUs, 1/2 of which vest 3/2/2027 and 1/2 of which vest 9/2/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 3/2/2026, the reporting person was granted 105,152 RSUs, 1/2 of which vest 3/2/2027 and 1/2 of which vest 9/2/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 3/2/2026, the reporting person was granted 157,729 RSUs, 1/2 of which vest 3/2/2027 and 1/2 of which vest 9/2/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 3/2/2026, the reporting person was granted 157,729 RSUs, 1/2 of which vest 3/2/2027 and 1/2 of which vest 9/2/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 3/2/2026, the reporting person was granted 210,305 RSUs, 1/2 of which vest 3/2/2027 and 1/2 of which vest 9/2/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.

Shares withheld by HP to satisfy tax withholding upon vesting.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

As previously reported, on 2/3/2025, the reporting person was granted 3,207 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 2/3/2025. DEUs accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 50 vested DEUs.

The 2,236 shares reported in column 9 includes 98 unvested DEUs reflected the Reporting Person's Form 3 filed November 10, 2025.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.175 to $23.215, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/25/2025.